» Articles » PMID: 38948917

Radiation Therapy Delivery During the 2023 Israel-Hamas War: Trust Prevails Over Fear

Overview
Specialty Oncology
Date 2024 Jul 1
PMID 38948917
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The attack by Hamas on Israeli civilians (October 7, 2023) triggered the ongoing war, which could be detrimental to cancer care in general and radiation therapy (RT) in particular. To assure continuity of care within the Radiation Oncology Department of Samson Assuta Ashdod University Hospital (SAAUH), which borders on Gaza, patient-centric measures were redoubled by our institution. This study describes the impact of these measures on patients' perception and their willingness to continue RT, despite fear of war.

Methods And Materials: A survey questionnaire was designed to detect changes in attitude and treatment adherence during war. It was offered to the patients undergoing RT at SAAUH. A Pearson correlation between the items relating to desire to continue the therapy was calculated. Smallest space analysis was conducted to illustrate the association between the variables.

Results: Forty-seven patients enrolled in this study reported a significantly lower feeling of personal safety during wartime in comparison with the confidence in the professionalism of the staff (paired samples test, t(43) = 4.61; < .001). Simultaneously, patients perceived that the impact of the national situation on their health was very low (mean of 1.59 on a scale of 1-6). Both the Pearson correlation test and smallest space analysis revealed that the desire to continue treatment in general and to continue treatment at the same department were significantly related to trust in the staff's professionalism.

Conclusions: Fear of war can pose a major pitfall in providing daily RT care. This obstacle may be potentially overridden by creating deep, trusting relationships between the patients and the medical staff.

References
1.
Chow R, Hasan S, Choi J, Fox J, Chhabra A, Marshall D . Effect of treatment interruptions on overall survival in patients with triple-negative breast cancer. J Natl Cancer Inst. 2023; 115(9):1029-1035. PMC: 10483262. DOI: 10.1093/jnci/djad127. View

2.
Petereit D, Sarkaria J, Chappell R, Fowler J, Hartmann T, Kinsella T . The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys. 1995; 32(5):1301-7. DOI: 10.1016/0360-3016(94)00635-X. View

3.
Ben-Josef E, Moughan J, Ajani J, Flam M, Gunderson L, Pollock J . Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11. J Clin Oncol. 2010; 28(34):5061-6. PMC: 3018356. DOI: 10.1200/JCO.2010.29.1351. View

4.
Yom S, Zietman A . Radiation Therapy in a Time of Disaster. Int J Radiat Oncol Biol Phys. 2018; 100(4):832-833. DOI: 10.1016/j.ijrobp.2017.12.001. View

5.
Gross J, Kruser J, Moran M, Kaiser K, Szmuilowicz E, Kircher S . Radiation Oncologists' Role in End-of-Life Care: A Perspective From Medical Oncologists. Pract Radiat Oncol. 2019; 9(5):362-370. DOI: 10.1016/j.prro.2019.04.001. View